These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2900221)
41. Actions of amino acids, amines and neuropeptides on target cells in the mammalian central nervous system. Zieglgänsberger W Prog Brain Res; 1982; 55():297-320. PubMed ID: 6187042 [No Abstract] [Full Text] [Related]
42. The role of neurotransmitters in stress-induced antinociception (SIA). Snow AE; Tucker SM; Dewey WL Pharmacol Biochem Behav; 1982 Jan; 16(1):47-50. PubMed ID: 6120525 [TBL] [Abstract][Full Text] [Related]
43. [Structural and functional organization of the cerebral dopaminergic system]. Barishpolets VV; Fedotova IuO; Sapronov NS Eksp Klin Farmakol; 2009; 72(3):44-9. PubMed ID: 19642593 [TBL] [Abstract][Full Text] [Related]
45. [Participation of the serotoninergic system of the brain in regulation of emotional reactivity]. Allikmets LKh; Zharkovskiĭ AM Zh Vyssh Nerv Deiat Im I P Pavlova; 1975; 25(6):1284-91. PubMed ID: 128934 [TBL] [Abstract][Full Text] [Related]
46. Neurotransmitter control of thyrotropin secretion. Krulich L Neuroendocrinology; 1982; 35(2):139-47. PubMed ID: 6127638 [TBL] [Abstract][Full Text] [Related]
50. Cerebral monoamine neurotransmitters in opioid withdrawal and dependence. Ahtee L; Attila LM Med Biol; 1987; 65(2-3):113-9. PubMed ID: 2888928 [TBL] [Abstract][Full Text] [Related]
51. Role of central nervous system neurotransmitters in mediating the effects of morphine on growth hormone- and prolactin-secretion in the rat. Koenig J; Mayfield MA; Coppings RJ; McCann SM; Krulich L Brain Res; 1980 Sep; 197(2):453-68. PubMed ID: 6105900 [TBL] [Abstract][Full Text] [Related]
52. Gamma-hydroxybutyrate, a possible neurotransmitter. Vayer P; Mandel P; Maitre M Life Sci; 1987 Sep; 41(13):1547-57. PubMed ID: 2887998 [No Abstract] [Full Text] [Related]
53. Attenuation of forgetting by pharmacological stimulation of aminergic neurotransmitter systems. Quartermain D; Judge ME; Leo P Pharmacol Biochem Behav; 1988 May; 30(1):77-81. PubMed ID: 2902645 [TBL] [Abstract][Full Text] [Related]
54. Dissociation of serotoninergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Mitra N; Mohanakumar KP; Ganguly DK Brain Res Bull; 1992 Mar; 28(3):355-64. PubMed ID: 1350496 [TBL] [Abstract][Full Text] [Related]
55. Serotonin-dopamine interaction and its relevance to schizophrenia. Kapur S; Remington G Am J Psychiatry; 1996 Apr; 153(4):466-76. PubMed ID: 8599393 [TBL] [Abstract][Full Text] [Related]
56. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies. Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155 [TBL] [Abstract][Full Text] [Related]
57. [Increase of the number of bone marrow T-suppressor cells under inhibition of immunogenesis during changes of the activity of the neuromediator system]. Idova GV; Cheĭdo MA; Al'perina EL Biull Eksp Biol Med; 1990 Sep; 110(9):287-9. PubMed ID: 1980087 [TBL] [Abstract][Full Text] [Related]
59. [Modulation of immune function by neurotransmitters and neuropeptides]. Qiu YH; Wang JH Sheng Li Ke Xue Jin Zhan; 1991 Jan; 22(1):21-4. PubMed ID: 1676539 [No Abstract] [Full Text] [Related]
60. Neuropharmacologic analysis of dopaminergic, cholinergic, and GABAergic brain systems in organizing the reflex to time. Mukhin EI Neurosci Behav Physiol; 1986; 16(3):215-22. PubMed ID: 2874521 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]